969
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden

, , , &
Article: 1660565 | Received 12 Feb 2019, Accepted 23 Aug 2019, Published online: 13 Sep 2019

References

  • Bjerg A, Ekerljung L, Middelveld R, et al. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA2LEN surveys. PLoS One. 2011;6(2):e16082.
  • Ekerljung L, Bjerg A, Bossios A, et al. Five-fold increase in use of inhaled corticosteroids over 18 years in the general adult population in West Sweden. Respir Med. 2014;108(5):685–10.
  • Global Initiative for Asthma (GINA). GINA report, global strategy for asthma management and prevention. 2017. [cited 2019 Aug 7]. Available from: https://ginasthma.org
  • Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals. Edition. 2017. [cited 2019 Aug 7]. Available from: https://goldcopd.org
  • Lundbäck B, Lindberg A, Lindström M, et al. Obstructive lung disease in northern Sweden studies. Not 15 but 50% of smokers develop COPD? — Report from obstructive lung disease in northern Sweden studies. Respir Med. 2003;97(2):115–122.
  • Hagstad S, Backman H, Bjerg A, et al. Prevalence and risk factors of COPD among never-smokers in two areas of Sweden – Occupational exposure to gas, dust or fumes is an important risk factor. Respir Med. 2015;109(11):1439–1445.
  • Negewo NA, Gibson PG, McDonald VMCOPD. and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171.
  • Swedish National Board of Health and Welfare Statistical database. [cited 2019 Aug 7]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/statistics/statistical-database
  • Ställberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45.
  • Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604.
  • Al-Jahdali H, Ahmed A, Al-Harbi A, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013;9(1):8.
  • Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5(4):1071–1081.r9.
  • Virchow JC, Rodriguez-Roisin R, Papi A, et al. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax compared to budesonide-formoterol Turbuhaler in adults and adolescents with persistent asthma. BMC Pulm Med. 2016;16:42.
  • Bosnic-Anticevich S, Callan C, Chrystyn H, et al. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices. J Asthma. 2018;55(1):79–88.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.